mesalamine has been researched along with Dermatitis Medicamentosa in 16 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mesalamine is a first-line drug in the treatment of inflammatory bowel diseases, while its intolerance occasionally occurs in clinical practice." | 2.61 | The culprit of mesalamine intolerance: case series and literature review. ( Fu, Y; Hong, F; Quan, R; Xie, C; Yan, W; Zou, K, 2019) |
| "We present the case of a woman with Crohn's disease who developed psoriasis after treatment with two anti-TNF- α drugs (infliximab and adalimumab)." | 1.37 | [Ustekinumab in a patient with Crohn's disease and anti-TNF-α-induced psoriasis]. ( Bosque López, MJ; Rocamora Durán, V; Royo Escosa, V; Sansó Sureda, A; Sapiña Camaró, A, 2011) |
| "5-aminosalicylates are extensively prescribed for the treatment of ulcerative colitis but have a wide range of described adverse effects." | 1.31 | Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines. ( Langman, MJ; Ransford, RA, 2002) |
| "Sulfasalazine is an important therapeutic agent in the management of chronic inflammatory bowel disease (CIBD)." | 1.28 | Sulfasalazine desensitization in children and adolescents with chronic inflammatory bowel disease. ( Tolia, V, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (12.50) | 18.7374 |
| 1990's | 6 (37.50) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 5 (31.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tarabar, D | 1 |
| Kandolf-Sekulović, L | 1 |
| Tatomirović, Ž | 1 |
| Mijušković, Ž | 1 |
| Milenković, Z | 1 |
| Tarabar, O | 1 |
| Pecelj-Broćić, T | 1 |
| Salman, A | 1 |
| Seckin Gencosmanoglu, D | 1 |
| Alahdab, YO | 1 |
| Giménez-Arnau, AM | 1 |
| Borges, AS | 1 |
| Valejo Coelho, MM | 1 |
| Fernandes, C | 1 |
| Brasileiro, A | 1 |
| Gonçalo, M | 1 |
| Xie, C | 1 |
| Quan, R | 1 |
| Hong, F | 1 |
| Zou, K | 1 |
| Yan, W | 1 |
| Fu, Y | 1 |
| Wanat, KA | 1 |
| Bandow, GD | 1 |
| Klekotka, PA | 1 |
| Sansó Sureda, A | 1 |
| Rocamora Durán, V | 1 |
| Sapiña Camaró, A | 1 |
| Royo Escosa, V | 1 |
| Bosque López, MJ | 1 |
| Ransford, RA | 1 |
| Langman, MJ | 1 |
| Aparicio, J | 1 |
| Carnicer, F | 1 |
| Girona, E | 1 |
| Gmez, A | 1 |
| Stelzle, RC | 1 |
| Squire, EN | 1 |
| Gibbon, KL | 1 |
| Bewley, AP | 1 |
| Thomas, K | 1 |
| Tolia, V | 1 |
| le Gros, V | 1 |
| Saveuse, H | 2 |
| Lesur, G | 2 |
| Brion, N | 1 |
| Legros, V | 1 |
| Rouveix, E | 1 |
| Brion, V | 1 |
| Parlier, H | 1 |
| Liot, F | 1 |
| Dorra, M | 1 |
| Boulain, T | 1 |
| Dorval, ED | 1 |
| Furet, J | 1 |
| Gillion, JM | 1 |
| Duval, G | 1 |
| Metman, EH | 1 |
| Cappello, M | 1 |
| Puleo, A | 1 |
| Calabrese, A | 1 |
| Cipolla, C | 1 |
| Orlando, A | 1 |
| Gatto, G | 1 |
| Oliva, L | 1 |
| Cottone, M | 1 |
| Grøn, I | 1 |
| Winther, A | 1 |
1 review available for mesalamine and Dermatitis Medicamentosa
| Article | Year |
|---|---|
The culprit of mesalamine intolerance: case series and literature review.
Topics: Abdominal Pain; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Diarrhea; Drug Eruptio | 2019 |
15 other studies available for mesalamine and Dermatitis Medicamentosa
| Article | Year |
|---|---|
Cutaneous side effects caused by treatment for inflammatory bowel disease.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cyclosporine; Drug E | 2016 |
Mesalazine-induced bullous fixed drug eruption.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Blister; Colitis, Ulcerative; Drug Eruptions; Foot D | 2018 |
Systemic allergic dermatitis caused by sodium metabisulfite in rectal enemas.
Topics: Administration, Rectal; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Colitis, Ulcerative; | 2018 |
Palmar-plantar erythrodysesthesia caused by mercaptopurine and mesalamine.
Topics: Acrodermatitis; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Crohn Disease; Drug | 2008 |
[Ustekinumab in a patient with Crohn's disease and anti-TNF-α-induced psoriasis].
Topics: Adalimumab; Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanize | 2011 |
Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Chemical and Drug Induced Liver Inju | 2002 |
Cutaneous hypersensitivity reaction to mesalazine.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Drug Eruptions; Humans; Male; Mesalam | 1996 |
Oral desensitization to 5-aminosalicylic acid medications.
Topics: Administration, Oral; Adolescent; Aged; Desensitization, Immunologic; Drug Eruptions; Drug Hypersens | 1999 |
Mesalazine-induced pustular drug eruption.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Diagnosis, Differential; Drug E | 2001 |
Sulfasalazine desensitization in children and adolescents with chronic inflammatory bowel disease.
Topics: Adolescent; Aminosalicylic Acids; Child; Chronic Disease; Desensitization, Immunologic; Diarrhea; Do | 1992 |
Lung and skin hypersensitivity to 5-aminosalicylic acid.
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Drug Eruptions; Drug Hypersensitivity; Female; Humans; Me | 1991 |
[Skin rash and lung hypersensitivity during treatment by 5-amino-salicylic acid].
Topics: Aminosalicylic Acids; Drug Eruptions; Female; Humans; Mesalamine; Middle Aged; Respiratory Hypersens | 1991 |
[Allergic reaction to lavage with mesalazine].
Topics: Adult; Aminosalicylic Acids; Drug Eruptions; Female; Humans; Mesalamine; Therapeutic Irrigation | 1990 |
[5-aminosalicylic acid treatment of ulcerative colitis during the acute phase in patients resistant or intolerant to salazopyrine].
Topics: Acute Disease; Adult; Aged; Aminosalicylic Acids; Colitis, Ulcerative; Drug Combinations; Drug Erupt | 1987 |
[Exanthema in 2 patients with ulcerative colitis treated with Pentasa].
Topics: Adult; Aged; Aminosalicylic Acids; Colitis, Ulcerative; Drug Eruptions; Exanthema; Humans; Male; Mes | 1988 |